FDA dementia trial guidance eases rules at ethical cost
Hanna Schmidt
20 Apr 2026·11m·💬 0
The FDA's new dementia trial guidance aims to accelerate drug development but raises serious ethical concerns about informed consent.
An FDA panel rejected a specific strain update for the fall COVID-19 vaccine, revealing tensions between scientific data and real-world readiness.